Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

Cibus, Inc.

(RTTNews) - Agricultural technology company Cibus, Inc. (CBUS) announced Friday key leadership changes pursuant to the Company's succession planning strategy. The Board has accepted Rory Riggs' resignation as the Company's Chief Executive Officer.
Peter Beetham, the Company's President and Chief Operating Officer, also will serve as the Company's Interim Chief Executive Officer. Beetham is a co-founder of Cibus Global with Riggs and with Greg Gocal, who will remain the Company's Chief Scientific Officer.
Riggs will remain Chairman of the Board of Directors and Beetham also will continue as a director.
The Board of Directors intends to initiate a search for the Company's next CEO and will consider external and internal candidates.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Cibus Names President And COO Peter Beetham Interim CEO As Rory Riggs Resigns

(RTTNews) - Cibus, Inc. (CBUS) announced on Wednesday the pricing of its public offering, which involves 3 million shares of Class A Common Stock priced at $4.00 each.
The agricultural biotechnology company has also provided underwriters with a 45-day option to purchase an additional 450,000 shares to address any over-allotments.
The company anticipates raising around $12 million in gross proceeds, prior to the deduction of underwriting discounts and expenses.
The company plans to use the net proceeds to advance the development of new seed traits, enhance existing traits, support Trait Machine operations, and for working capital and general corporate needs.
The offering is expected to close on September 19, 2024, with Roth Capital Partners and A.G.P./Alliance Global Partners serving as joint book-running managers for the transaction.
Currently, CBUS's stock is trading at $3.78, down 25.30% on the Nasdaq.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	0.00 23.75
Price/Sales	21.24 3.01
P/B	1.45 2.20
P/FCF	0.00 18.30

Indicator	TTM Median
ROE	-187.57 25.41
ROA	-89.09 6.00
Net Worth	0.13 0.20
Quick Ratio	0.00 1.71
Current Ratio	1.44 2.83

Indicator	TTM Median
EPS	0.06 0.37
EPS Forecast	0.90 0.37
Revenue	1.00M 16.00M
Gross Profit	2.00M —
EBITDA	-17.00M —

Cibus, Inc.

TTM metrics for the latest quarter under IFRS and their historical dynamics

Valuation

Debts

Efficiency

Other ratios

Revenue